نوفا سيفتي Nova cefti 100ML

Each 100 mL of Nova-Cefti Sterile Suspension for Injection contains: Active: Ceftiofur Hydrochloride. Inactive Substances: Silicon Dioxide, Butylated Hydroxytoluene (BHT), Polysorbate 80 (Tween 80) and Propylene Glycol Dicaprylate. INDICATIONS: .5,000mg Use for the treatment of bacterial respiratory disease associated with Mannheimia haemolytica, Pasteurella multocida and Histophilus somni, for acute interdigital necrobacillosis (panaritium, foot rot) associated with Fusobacterium necrophorum and Bacteroides melaninogenicus (Porphyromonas asaccharolytica), and treatment of the bacterial component of acute post- partum (puerperal) metritis associated with Escherichia coli, Arcanobacterium pyogenes and Fusobacterium necrophorum (restricted to cases where treatment with another antimicrobial has failed). CONTRAINDICATIONS: Do not administer to an animal previously found to be hypersensitive to ceftiofur and other B-lactam antibiotics. Do not inject intravenously. Do not use in poultry (including eggs) due to risk of spread of antimicrobial resistance to humans. WITHDRAWAL TIME: Meat: 8 days Milk: Zero day STORAGE: Do not store above 30°C. Protect from light. LOT NO. , MFG. DATE, EXP. DATE: SEE AT THE BOTTOM 8 93600711539606 CAUTIONDOSAGE AND METHOD OF ADMINISTRATION: By subcutaneous injection Treatment of respiratory disease: 1 mL/25-50 kg body weight once a day, for 3 to 5 days. Treatment of acute interdigital necrobacillosis: 1 mL/25- 50 kg body weight once a day, for 3 days. For Acute post-partum metritis: 1 mL/25-50 kg body weight once a day, for 5 consecutive days. RECOMMENDATION: Shake well before use. Multiple injection must be given at different sites. In case of acute post-partum metritis, additional supportive therapy might be required in some cases. To ensure a correct dosage, body weight should be determined as accurately as possible to avoid underdosing.